Lataa...

Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management

Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare and disabling disorder of fibroblast growth factor 23 (FGF23) deficiency or resistance. The disorder is manifest by hyperphosphatemia, inappropriately increased tubular reabsorption of phosphate and 1,25-dihydroxy-Vitamin D, and ectopic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Endocrinol (Lausanne)
Päätekijät: Boyce, Alison M., Lee, Alisa E., Roszko, Kelly L., Gafni, Rachel I.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225339/
https://ncbi.nlm.nih.gov/pubmed/32457699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00293
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!